Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade A 228.29 1.06% 2.40
ABMD closed up 1.06 percent on Friday, January 19, 2018, on 61 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Feb 1

9 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABMD trend table...

Date Alert Name Type % Chg
Jan 19 New 52 Week Closing High Bullish 0.00%
Jan 19 New 52 Week High Strength 0.00%
Jan 19 Upper Bollinger Band Walk Strength 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 19 Overbought Stochastic Strength 0.00%
Jan 19 Up 3 Days in a Row Strength 0.00%
Jan 19 Up 4 Days in a Row Strength 0.00%
Jan 19 Up 5 Days in a Row Strength 0.00%
Jan 18 New 52 Week Closing High Bullish 1.06%
Jan 18 New 52 Week High Strength 1.06%

Older signals for ABMD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 229.05
52 Week Low 103.53
Average Volume 292,741
200-Day Moving Average 161.2186
50-Day Moving Average 197.6968
20-Day Moving Average 203.556
10-Day Moving Average 214.968
Average True Range 4.1968
ADX 36.4
+DI 49.56
-DI 8.0
Chandelier Exit (Long, 3 ATRs ) 216.4596
Chandelier Exit (Short, 3 ATRs ) 199.6004
Upper Bollinger Band 229.6605
Lower Bollinger Band 177.4515
Percent B (%b) 0.97
BandWidth 25.64847
MACD Line 8.6756
MACD Signal Line 5.7754
MACD Histogram 2.9001
Fundamentals Value
Market Cap 10.07 Billion
Num Shares 44.1 Million
EPS 1.71
Price-to-Earnings (P/E) Ratio 133.50
Price-to-Sales 16.68
Price-to-Book 13.96
PEG Ratio 2.75
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 232.73
Resistance 3 (R3) 232.49 230.77 231.99
Resistance 2 (R2) 230.77 229.64 230.89 231.74
Resistance 1 (R1) 229.53 228.94 230.15 229.77 231.50
Pivot Point 227.81 227.81 228.12 227.93 227.81
Support 1 (S1) 226.57 226.68 227.19 226.81 225.08
Support 2 (S2) 224.85 225.98 224.97 224.84
Support 3 (S3) 223.61 224.85 224.59
Support 4 (S4) 223.85